{"slideshow_credits": null, "snippet": "The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.", "abstract": "Food and Drug Administration approves highly anticipated Pfizer drug Ibrance, used to treat postmenopausal women with specific type of advanced breast cancer.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/02/04/business/pfizer-breast-cancer-drug-wins-federal-approval.html", "lead_paragraph": "The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.", "headline": {"main": "Pfizer Breast Cancer Drug Wins Federal Approval ", "content_kicker": "Business Briefing", "print_headline": "Pfizer Breast Cancer Drug Wins Federal Approval"}, "_id": "54d1653538f0d86a52397ae3", "word_count": "120", "multimedia": [], "pub_date": "2015-02-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Breast Cancer", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}